Нове вакцине у фокусу СЗО: охрабрујући резултати, али без журбе
Вакцине за лечење рака и ХИВ-а су обећавајуће и имају шансе за успех, изјавио је данас Батир Бердикличев, шеф канцеларије Светске здравствене организације (СЗО) у Русији.
TL;DR
- mRNA vaccines for cancer therapy are considered a promising innovative platform.
- Early clinical trials suggest these vaccines can stimulate the immune system and show positive results in certain cancers.
- Most current data is preliminary and relates to small patient groups.
- Larger, long-term studies are required to confirm the effectiveness of mRNA vaccines for various cancers.
- The WHO does not currently have any approved mRNA vaccines for cancer treatment.
- Vaccine research for HIV therapy is also in progress but remains in the development and testing phase.
- The WHO recommended lenacapavir, an injectable drug administered twice a year, for HIV pre-exposure prophylaxis in 2025.
- Lenacapavir simplifies prevention for infected individuals.
- Prospects for effective cancer and HIV treatments are encouraging but require scientific rigor and caution.